Retinol binding protein 4 is associated with adiposity-related co-morbidity risk factors in children

Journal of Pediatric Endocrinology and Metabolism

Volumn 24, Issue 11-12, 2011, Pages 913-919

  Conroy, Rushika ^a   Espinal, Yomery ^a   Fennoy, Ilene ^a   Accacha, Siham ^d   Boucher Berry, Claudia ^c   Carey, Dennis E ^c   Close, Sharron ^a   DeSantis, Deborah ^b   Gupta, Rishi ^d   Hassoun, Abeer A ^a   Iazzetti, Loretta ^c   Jacques, Fabean J ^d   Jean, Amy M ^a   Michel, Lesly ^d   Pavlovich, Katherine ^a   Rapaport, Robert ^e   Rosenfeld, Warren ^d   Shamoon, Elisabeth ^a   Shelov, Steven ^b   Speiser, Phyllis W ^c   Ten, Svetlana ^b   Rosenbaum, Michael ^a   more..

^a NewYork Presbyterian Hospital   (United States)

^b MAIMONIDES MEDICAL CENTER   (United States)

^c Northwell Health   (United States)

^d WINTHROP UNIVERSITY HOSPITAL   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

inflammation; insulin resistance; lipids; obesity

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RETINOL BINDING PROTEIN 4; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL OBESITY; ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DYSLIPIDEMIA; ETHNIC DIFFERENCE; FEMALE; GLUCOSE DISPOSAL INDEX; GLUCOSE HOMEOSTASIS; HUMAN; HYPERTENSION; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OBESITY; QUANTITATIVE ANALYSIS; RISK FACTOR; SCHOOL CHILD; WAIST CIRCUMFERENCE;

ADIPOSITY; ADOLESCENT; BLOOD GLUCOSE; BODY COMPOSITION; CHILD; COMORBIDITY; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LIPIDS; MALE; OBESITY; PREVALENCE; RETINOL-BINDING PROTEINS, PLASMA; RISK FACTORS;

EID: 83655190876     PISSN: 0334018X     EISSN: 21910251     Source Type: Journal    
DOI: 10.1515/JPEM.2011.297     Document Type: Article

References (37)

1. Rosenbaum M. Epidemiology of pediatric obesity. Pediatr Annals 2007;36:89-95. (Pubitemid 46423617)
2. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WM. Prevalence of a metabolic syndrome phenotype in adolescents: fi ndings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 2003;157:821-7. (Pubitemid 36988016)
3. Dablea D, Pettitt D, Jones K, Arslanian S. Type 2 diabetes melli-tus in minority children and adolescents. Endocrinol Metab Clin N Am 1999;28:709-29.
4. Caprio S, Tamborlane W. The metabolic impact of obesity in childhood. Endocrinol Metab Clin N Am 1999;28:731-47.
5. Lee YS. Consequences of childhood obesity. Annals Acad Med 2009;38:75-81.
6. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005;436:356-62. (Pubitemid 41065039)
7. Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, et al. Retinol-binding protein 4 and insulin resistance in lean, obese and diabetic subjects. N Engl J Med 2006;354:2552-63. (Pubitemid 43882351)
8. von Eynatten M, Lepper PM, Liu D, Lang K, Baumann M, et al. Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease. Diabetologia 2007;50:1930-7. (Pubitemid 47222861)
9. Broch M, Vendrell J, Ricart W, Richart C, Fernandez-Real JM. Circulating retinol-binding protein-4, insulin sensitivity, insulin secretion, and insulin disposition index in obese and non-obese subjects. Diabetes Care 2007;30:1802-6. (Pubitemid 47036355)
10. Seo JA, Kim NH, Park SY, Kim HY, Ryu OH, et al. Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease. Clin Endocrinol 2008;68:555-60. (Pubitemid 351388698)
11. Qi Q, Yu Z, Xingwang Y, Zhao F, Huang P, et al. Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. J Clin Endocrinol Metab 2007;92: 4827-34. (Pubitemid 350223466)
12. Kowalska I, Straczkowski M, Adamska A, Nikolajuk A, Karczewska-Kupczewska M, et al. Serum retinol binding protein 4 is related to insulin resistance and non-oxidative glucose metabolism in lean and obese women with normal glucose tolerance. J Clin Endocrinol Metab 2008;93:2786-9. (Pubitemid 352008552)
13. Yeste D, Vendrell J, Tomasini R, Gallart LL, Clemente M, et al. Retinol-binding protein 4 levels in obese children and adolescents with glucose intolerance. Horm Res Paediatr 2010;73:335-40.
14. Balagopal P, Graham TE, Kahn BB, Altomare A, Funanage V, et al. Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical infl ammation. J Clin Endocrinol Metab 2007;92:1971-4. (Pubitemid 46997219)
15. Reinehr T, Stoffel-Wagner B, Roth CL. Retinol-binding protein 4 and its relation to insulin resistance in obese children before and after weight loss. J Clin Endocrinol Metab 2008;93:2287-93. (Pubitemid 351831549)
16. Lee DC, Lee JW, Im JA. Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents. Metabolism 2007;56:327-31.
17. Aeberli I, Biebinger R, Lehmann R, l'Allemand D, Spinas GA, et al. Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children. J Clin Endocrinol Metab 2007;92:4359-65. (Pubitemid 350074757)
18. Rosenbaum M, Accacha S, Altshuler L, Carey DE, Fennoy I, et al. The reduce obesity and diabetes (ROAD) project: design and methodological considerations. Child Obes 2011;7:223-34.
19. World Medical Association, American Physiological Society. Guiding principles for research involving animals and human beings. Am J Physiol Regul Integr Comp Physiol 2002;283:R281-3.
20. Katz A, Nambi S, Mather K, Baron AD, Follmann DA, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-10. (Pubitemid 32269192)
21. Zethelius B, Byberg L, Hales C, Lithell H, Berne C. Proinsulin and acute insulin response independently predict type 2 diabetes mellitus in men-report from 27 years of follow-up study. Diabetologia 2003;46:20-6. (Pubitemid 36237742)
22. Kahn S. The relative contributions of insulin resistance and β-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 2003;46:3-19. (Pubitemid 36237741)
23. Rosenbaum M, Nonas C, Horlick M, Fennoy I, Vargas I, et al., and the EI Camino diabetes prevention group. Beta-cell function and insulin sensitivity in early adolescence: association with body fatness and family history of type 2 diabetes mellitus. J Clin Endocrinol Metab 2004;89:5469-76. (Pubitemid 39523131)
24. Rosenbaum M, Nonas C, Weil R, Horlick M, Fennoy I, et al., and the EI Camino diabetes prevention group. School-based intervention acutely improves insulin sensitivity and decreases infl ammatory markers and body fatness in junior high school students. J Clin Endocrinol Metab 2007;92:504-8.
25. Rothman K. No adjustments are needed for multiple comparisons. Epidemiol 1990;1:43-6. (Pubitemid 20255621)
26. Perneger T. What's wrong with Bonferroni adjustments. Br Med J 1998;316:1236-8. (Pubitemid 28171344)
27. Thomas D, Siemiatycki J, Dewar R, Robins J, Goldberg M, et al. The problem of multiple inference in studies designed to generate hypotheses. Am J Epidemiol 1985;122:1080-95. (Pubitemid 16170043)
28. Rhie YJ, Choi BM, Eun SH, Son CS, Park SH, et al. Association of serum retinol binding protein 4 with adiposity and pubertal development in Korean children and adolescents. J Korean Med Sci 2011;26:797-802.
29. Wilson PW, D'Agostino RB, Levy D, Belanger A, Silbershatz H, et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47. (Pubitemid 28213628)
30. Nobili V, Alkhouri N, Alisi A, Ottino S, Lopez R, et al. Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric non-alcoholic fatty liver disease. Clin Gastroenterol Hepatol 2009;7:575-9.
31. Schina M, Koskinas J, Tiniakos D, Hadziyannis E, Savvas S, et al. Circulating and liver tissue levels of retinol-binding protein-4 in non-alcoholic fatty liver disease. Hepatol Res 2009; 39:972-8.
32. Alkhouri N, Lopez R, Berk M, Feldstein AE. Serum retinol-binding protein 4 levels in patients with non-alcoholic fatty liver disease. J Clin Gastroenterol 2009;43:985-9.
33. Adams TC, Hasson RE, Lane CJ, Davis JN, Weigensberg MJ, et al. Fasting indicators of insulin sensitivity: effects of ethnicity and pubertal status. Diab Care 2011;34:994-9.
34. Annaswamy R, Seely EW, Arky RA, Simonson DC. Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab 2001;86:5366-71. (Pubitemid 33070261)
35. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol 2010;316:129-39.
36. Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002;13:84-9. (Pubitemid 36740452)
37. Moran A, Jacobs Jr DR, Steinberger J, Steffen LM, Pankow JS, et al. Changes in insulin resistance and cardiovascular risk during adolescence. Circulation 2008;117:2361-8.